- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01816438
A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia
A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia in Intestinal Inflammatory Diseases
The main purpose is to describe clinical practices nowadays prospectively about patients with a dysplasia diagnosis or another histological lesions.
It will be identified colic situation during the initial colonoscopy after dysplasia diagnosis or atypical lesion.
Also the frequency and the type of monitoring conducted about these patients(surgical and endoscopic treatments).
The main criterion evaluation will be the surgical and endoscopic rates during the time.
The treatments offered such as surgical, endoscopic ones or none of them will be followed.
Finally, the outcome of these patients: stability, lesion disappearance, surgery or development of cancer with frequencies for each of them and relationships with histological abnormal colorectal lesion will be measured.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Rhône Alpes
-
Lyon, Rhône Alpes, France, 69473
- Edouard Herriot Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- intestinal chronic inflammatory disease with at least one lesion such as hyperplasia or no dysplastic scalloped lesion, dysplastic scalloped lesion or low grade dysplasia or high grade dysplasia
- compliant patient
- endoscopic follow possible
- no settler cancer
- no serious pathology such as cancer
Exclusion Criteria:
- settler cancer
- serious pathology such as cancer
- no compliant patient
- endoscopic follow not possible
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
dysplasia or colorectal lesion
300 patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
endoscopies results
Time Frame: 4 years
|
rates of surgery and endoscopic treatments frequency of development of a cancer or a high grade dysplasia according to a type of abnormal histological colorectal lesion
|
4 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Saurin Jean Christophe, MSD, no affiliated
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SFED N°100
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperplasia
-
University of PennsylvaniaFood and Drug Administration (FDA); EUSA Pharma, Inc.; Castleman Disease Collaborative...RecruitingCastleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Hyperplasia, Giant Lymph Node | Lymph Node Hyperplasia, GiantUnited States
-
St. Joseph's Healthcare HamiltonOntario Ministry of Health and Long Term CareCompletedBenign Prostatic HyperplasiaCanada
-
GlaxoSmithKlineCompletedBenign Prostatic Hyperplasia
-
Castleman Disease Collaborative NetworkWithdrawnHyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Giant Lymph NodeUnited States
-
Samsung Medical CenterCompletedFocal Nodular HyperplasiaKorea, Republic of
-
Hongguo RongNot yet recruiting
-
SB Istanbul Education and Research HospitalUnknown
-
University of PennsylvaniaCastleman Disease Collaborative NetworkCompletedHyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNHUnited States
-
Societatea Romana de Ultrasonografie in Medicina...Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian... and other collaboratorsUnknownLiver Metastases | Focal Nodular Hyperplasia of Liver | Toxic Liver Disease With Focal Nodular HyperplasiaRomania
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting